Ion channels

Ion channel modulators for ultra-rare genetic disorder 

15 December 2022

Metrion Biosciences, a specialist ion channel contract research and drug discovery company, and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra-rare genetic disorder, have entered a collaboration to progress a hit identification research project for small molecule modulators of the potassium ion channel Kv3.1, targeting KCNC1-related disorders […]

Metrion Biosciences and Sosei Heptares form strategic drug discovery collaboration

1 February 2021

Metrion Biosciences, the specialist ion channel CRO and drug discovery company and Sosei Group, an international biopharmaceutical group, will apply Sosei Heptares’ structure-based drug design (SBDD) expertise and platform to ion channels for the first time through a new strategic collaboration. Ion channels are a class of integral membrane proteins that regulate the flow of […]